Cargando…

HIV Infection, Antiretroviral Therapy and Cardiovascular Risk

In the last 15 years, highly active antiretroviral therapy (HAART) has determined a dramatic reduction of both morbidity and mortality in human immunodeficiency virus (HIV)-infected subjects, transforming this infection in a chronic and manageable disease. Patients surviving with HIV in the develope...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Gaetano Donati, Katleen, Cauda, Roberto, Iacoviello, Licia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134220/ https://www.ncbi.nlm.nih.gov/pubmed/21776340 http://dx.doi.org/10.4084/MJHID.2010.034

Ejemplares similares

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study
por: De Luca, Andrea, et al.
Publicado: (2013)

Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy
por: Tumbarello, Mario, et al.
Publicado: (2004)

Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials
por: Di Castelnuovo, Augusto, et al.
Publicado: (2021)

Chloroquine/hydroxycloroquine and COVID-19: need to know more about
por: Cassone, Antonio, et al.
Publicado: (2020)

Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals
por: Trecarichi, Enrico M, et al.
Publicado: (2006)

A Socioeconomic Paradox in the COVID-19 Pandemic in Italy: a Call to Study Determinants of Disease Severity in High and Low-Income Countries
por: Bonaccio, Marialaura, et al.
Publicado: (2020)

Editorial: Trends in Digital Medicine
por: Capobianco, Enrico, et al.
Publicado: (2020)

Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008)

Impact of Antiretroviral Therapy on the Risk of Recurrence in HIV-1 Infected Patients with Kaposi Sarcoma: A Multicenter Cohort Experience
por: Colafigli, Manuela, et al.
Publicado: (2019)

New challenges from Covid-19 pandemic: an unexpected opportunity to enlighten the link between viral infections and brain disorders?
por: Gialluisi, Alessandro, et al.
Publicado: (2020)

Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report
por: Trecarichi, Enrico Maria, et al.
Publicado: (2011)

Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy
por: Muhammad, Sanusi, et al.
Publicado: (2013)

Impact of Nationwide Lockdowns Resulting from the First Wave of the COVID-19 Pandemic on Food Intake, Eating Behaviors, and Diet Quality: A Systematic Review
por: Mignogna, Cristiana, et al.
Publicado: (2021)

Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
por: Bavinger, Clay, et al.
Publicado: (2013)

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)

Incremental monounsaturated to saturated fat ratio and fibre consumption is associated with a reduction in a composite score of modifiable cardiovascular risk factors: Prospective results from the Moli-sani study
por: Ruggiero, Emilia, et al.
Publicado: (2022)

Machine Learning Approaches for the Estimation of Biological Aging: The Road Ahead for Population Studies
por: Gialluisi, Alessandro, et al.
Publicado: (2019)

Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities
por: Izzi, Benedetta, et al.
Publicado: (2020)

Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution
por: van Wijk, Jeroen P. H., et al.
Publicado: (2012)

The Impact of a Health Promotion Educational Program on Cardiovascular Risk Factors for HIV Infected Women on Antiretroviral Therapy
por: Hodges, Samaha, et al.
Publicado: (2013)

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
por: Prosperi, Mattia CF, et al.
Publicado: (2012)

Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
por: Bloch, Mark, et al.
Publicado: (2014)

Psychological Resilience, Cardiovascular Disease, and Metabolic Disturbances: A Systematic Review
por: Ghulam, Anwal, et al.
Publicado: (2022)

START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection
por: Siedner, Mark J.
Publicado: (2016)

Low antithrombin levels are associated with low risk of cardiovascular death but are a risk factor for cancer mortality
por: Iacoviello, Licia, et al.
Publicado: (2022)

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings
por: Peterson, Kevin, et al.
Publicado: (2011)

Association of Psychological Resilience with All-Cause and Cardiovascular Mortality in a General Population in Italy: Prospective Findings from the Moli-Sani Study
por: Ghulam, Anwal, et al.
Publicado: (2021)

Metabolic Syndrome Prevalence and Cardiovascular Risk Assessment in HIV-Positive Men with and without Antiretroviral Therapy
por: Lu, Win-Long, et al.
Publicado: (2021)

Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa
por: Reda, Ayalu A., et al.
Publicado: (2012)

French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults
por: Hoen, Bruno, et al.
Publicado: (2014)

γδ T‐cell responses during HIV infection and antiretroviral therapy
por: Juno, Jennifer A, et al.
Publicado: (2019)

Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected individuals in Durban, South Africa
por: Todowede, Olamide O., et al.
Publicado: (2019)

Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk
por: Leite, Kaliene Maria Estevão, et al.
Publicado: (2020)

Immediate antiretroviral therapy in young HIV-infected children: benefits and risks
por: Collins, Intira J., et al.
Publicado: (2014)

Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation
por: Barlow-Mosha, Linda, et al.
Publicado: (2017)

Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy
por: Winston, Alan, et al.
Publicado: (2013)

An Outlook on the Impact of HIV Infection and Highly Active Antiretroviral Therapy on the Cardiovascular System – A Review
por: Antony, Ishan, et al.
Publicado: (2020)

Life's Simple 7 for cardiovascular health is associated with cancer risk in the Moli-sani Study
por: onaccio, M B, et al.
Publicado: (2023)

Metabolic syndrome, insulin resistance and the risk of cardiovascular disease in HIV patients undergoing antiretroviral therapy
por: Tilişcan, Cătălin, et al.
Publicado: (2013)

Hydroxichloroquine for COVID-19 infection: Do we have a final word after one year?
por: Di Castelnuovo, Augusto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9hvh1cbdf554evfb3j2d1d2mt